Beyond Installation, Operational, and Performance Qualifications: A Risk-Based Validation Framework for AI-Driven Software in ...

Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...

Preliminary H1 2026 revenue of approximately $11 million, increased 120% vs. H1 2025, underscoring strong operating momentum. Supported by approximately $495 million in cash and short-term investments ...

Blue Moon Metals Inc. ("Blue Moon" or the "Company") , is pleased to provide an update on its fully integrated 2026 ...

(NYSE American: BURU), the next-generation dual-use Defense & Security integrated platform company focused on non-kinetic effects and directed-energy technologies, electronic warfare and defense ...

For most of the past decade, organic marketers have operated with a clear north star: visibility. Get on Page 1. Get in the featured snippet. Get seen. That north star has now moved. The question I ...

For more than a century, tissue biopsies have stood as the gold standard for diagnosing cancer. And for good reason. These tiny tumour samples can unlock a wealth of molecular information, information ...

Aminuddin, the KPK Deputy for Prevention, explained that his party provided the BGN with ten study recommendations.

Radiation therapy remains a central modality in cancer treatment, but normal-tissue toxicity and long-term stochastic effects ...

TORONTO, July 7, 2026 /PRNewswire/ - Blue Moon Metals Inc. ("Blue Moon" or the "Company") (TSXV: MOON) (NASDAQ: BMM), is pleased to provide an update on its fully integrated 2026 exploration ...

Background Adult-onset Still’s disease (AOSD) is a systemic autoinflammatory disorder lacking a gold-standard diagnostic ...